483 Teva Parenteral Manufacturing Jun 2013

483 Teva Parenteral Manufacturing Jun 2013

Carla Lundi FDA, Marcus Yambot FDA$119.00 - Available Now

FDA investigators audited the Teva Parenteral Manufacturing - Irvine, CA, United States facility and issued inspectional observations (via FDA 483) on 04 Jun 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 04 Jun 2013
  • Location: Irvine, United States
  • FEI: 2027158
Add To Cart